Impact of biomarker usage on oncology drug development

E-ISSN： 1365-2710|38|1|62-67

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.38, Iss.1, 2013-02, pp. : 62-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of biomarker usage on oncology drug development

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 269-4727, Iss. 1, 2013-02 ,pp. : 62-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

A matrix approach to guide IHC‐based tissue biomarker development in oncology drug discovery

THE JOURNAL OF PATHOLOGY, Vol. 232, Iss. 2, 2014-01 ,pp. : 190-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model‐Based Drug Development in Oncology: What's Next?

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 4, 2013-04 ,pp. : 303-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Impact of Preclinical Irreproducibility on Drug Development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 1, 2015-01 ,pp. : 16-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing the Value-Adding Impact of Diagnostic-Type Tests on Drug Development and Marketing

By Blair Edward D.

Molecular Diagnosis & Therapy, Vol. 12, Iss. 5, 2008-01 ,pp. : 331-337

Adis International

Access to resources Recommend Favorite